How Purdue Used Misleading Charts to Hide OxyContin's ... - CBS News
Sep 28, 2011 · A case filed by the Commonwealth of Kentucky against Purdue Pharma sheds new light on the origin of an infamously misleading chart showing that OxyContin stays in …
Who Signed Off on Purdue's Misleading OxyContin Chart? Judge ... - CBS News
Jan 7, 2010 · According to Philip Thomas, an attorney petitioning the FDA to change OxyContin's labelling, the log chart was used by Purdue's sales reps to persuade doctors that OxyContin …
Business Communication and Character - Skewed Chart Example
Nov 6, 2021 · Dopesick on Hulu includes a great example of a compressed chart scale. The show is about the opioid crisis and features the Sackler family and Purdue Pharma’s role in …
A History of Dangerously Misleading Data Visualization
Sep 15, 2021 · In the graph on the left, the graph produced by Purdue Pharma as part of their marketing package, a logarithmic y-axis is presented, making the rate of change look smaller …
How misleading marketing got America addicted - The Washington Post
On Feb. 10, drugmaker Purdue Pharma, creator of OxyContin, announced it had sliced its sales force in half and would stop promoting opioids to doctors, a problematic marketing strategy that...
Sacklers Directed Efforts to Mislead Public About OxyContin, …
Jan 15, 2019 · A filing in a Massachusetts lawsuit contains dozens of internal Purdue Pharma documents suggesting the family was far more involved than the company has long contended.
Data Touted by OxyContin Maker to Fight Lawsuits Doesn’t ... - ProPublica
Purdue Pharma has tried to refute accusations that it fueled the opioid crisis by arguing it was a small player in the U.S. market for prescription pain relievers.
Key Charts - Judge for Yourselves
All Opioid Prescriptions: 1992–2018. U.S. Drug Overdose Deaths Involving Opioids: 1999–2019 [5] Substantial Amounts of Unrestricted Cash on Hand Remained at Purdue After …
How Purdue planted its 'anti-story' to downplay risks of OxyContin - STAT
Nov 19, 2019 · I n 2004, Purdue Pharma was facing a threat to sales of its blockbuster opioid painkiller OxyContin, which were approaching $2 billion a year. With abuse of the drug on the …
The history of OxyContin, told through Purdue Pharma …
Dec 3, 2019 · STAT’s multiyear legal battle to unseal Purdue files has produced dozens of documents that lay bare new details about its OxyContin marketing campaign.